Infliximab Reverses Suppression of Cholesterol Efflux Proteins by TNF-α: A Possible Mechanism for Modulation of Atherogenesis

Tumor necrosis factor- (TNF-) α is a proinflammatory proatherogenic cytokine. Infliximab, an anti-TNF-α monoclonal antibody, is effective in treating rheumatoid arthritis. However, its impact on cardiovascular burden and lipid transport is unclear. The present study investigates the effect of TNF-α...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Voloshyna, Iryna, Seshadri, Sangeetha, Anwar, Kamran, Littlefield, Michael J., Belilos, Elise, Carsons, Steven E., Reiss, Allison B.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3920897/
https://ncbi.nlm.nih.gov/pubmed/24587984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/312647
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados